Deficient or aberrant FGF21 is associated with NAFLD/NASH, and elevated FGF21 serum levels correlate with hepatic fat content in mice and humans (reviewed in [37]). Here, FGF21 is linked to metabolic dysfunction-associated steatohepatitis.